EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lower (1,3)-beta-d-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains

Malgorzata Mikulska, Nadir Ullah, Laura Magnasco, Giulia Codda, Claudia Bartalucci, Franca Miletich, Chiara Sepulcri, Edward Willison, Antonio Vena, Daniele R Giacobbe, Vincenzo di Pilato, Chiara Robba und 3 weitere

Clinical Microbiology and Infection · 2024

DOI: 10.1016/j.cmi.2024.02.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2024. Verfasst von Malgorzata Mikulska und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genova, Genova, Italy; Division of Infectious Diseases, IRCCS …. Hauptthemen laut MEDLINE: beta-Glucans, Candidemia, Candida parapsilosis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: The serum (1,3)-beta-d-glucan (BDG) assay gives quicker results and has higher sensitivity than blood cultures, therefore it is advised for early diagnosis of invasive candidemia and/or discontinuation of empirical therapy. Its sensitivity may depend on different factors. The aim of our study was to analyse the in vitro and in vivo BDG levels in clinical isolates of three species of Candida responsible for candidemia. METHODS: C. albicans, C. parapsilosis, and C. auris strains were collected from blood cultures of patients who had a concurrent (-1 to +3 days) serum BDG test (Fungitell assay). Supernatants of all strains were tested in quadruplicate for BDG levels. RESULTS: Twenty-two C. auris, 14 C. albicans, and ten C. parapsilosis strains were included. The median BDG levels in supernatants were 463 pg/mL (interquartile range [IQR] 379-648) for C. auris, 1080 pg/mL (IQR 830-1276) for C. albicans, and 755 pg/mL (IQR 511-930) for C. parapsilosis, with the significant difference among the species (p < 0.0001). Median serum BDG levels (IQR) were significantly lower in case C. auris and C. parapsilosis vs. C. albicans (p < 0.0001), respectively, 50 pg/mL (IQR 15-161) and 57 pg/mL (IQR 18-332), vs. 372 pg/mL (IQR 102-520). Sensitivity of serum BDG was 39% (95% confidence interval [CI], 18-64) in case of C. auris, 30% (95% CI, 8-65) C. parapsilosis and 78% (95% CI, 49-94) C. albicans candidemia. DISCUSSION: In our centre C. auris and C. parapsilosis strains have lower BDG content as compared with C. albicans, with a potential impact on serum BDG performance for the diagnosis of candidemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-GlucansCandidemiaCandida parapsilosisHumansMaleFemaleMiddle AgedCandida aurisAgedProteoglycansCandida albicansSensitivity and SpecificityAdultMicrobial Sensitivity TestsCandidaAntifungal AgentsAged, 80 and over

Stichwörter der Autor:innen

Candida albicansCandida aurisCandida parapsilosisCandidemiaDe-escalationGlucan

Substanzen

beta-GlucansProteoglycanspolysaccharide-KAntifungal Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genova, Genova, Italy; Division of Infectious Diseases, IRCCS Ospedale Policlinico San Martino, Genova, Italy. Electronic address: m…
  • Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genova, Genova, Italy.
  • Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Genoa, Italy.
  • Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genova, Genova, Italy; Division of Infectious Diseases, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Microbiology Unit, San Martino Policlinico Hospital - IRCCS for Oncology and Neurosciences, Genoa, Italy.
  • Anesthesia and Intensive Care, Ospedale Policlinico San Martino, IRCCS per l'Oncologia e le Neuroscienze, Genoa, Italy.

Zitieren

APA

Mikulska, M., Ullah, N., Magnasco, L., Codda, G., Bartalucci, C., Miletich, F., Sepulcri, C., Willison, E., Vena, A., Giacobbe, D. R., di Pilato, V., Robba, C., Ball, L., Marchese, A., & Bassetti, M. (2024). Lower (1,3)-beta-d-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2024.02.012

Vancouver

Mikulska M, Ullah N, Magnasco L, Codda G, Bartalucci C, Miletich F, et al. Lower (1,3)-beta-d-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains. Clinical Microbiology and Infection. 2024. doi:10.1016/j.cmi.2024.02.012

BibTeX
@article{Mikulska2024,
  author = {Mikulska, Malgorzata and Ullah, Nadir and Magnasco, Laura and Codda, Giulia and Bartalucci, Claudia and Miletich, Franca and Sepulcri, Chiara and Willison, Edward and Vena, Antonio and Giacobbe, Daniele R and di Pilato, Vincenzo and Robba, Chiara and Ball, Lorenzo and Marchese, Anna and Bassetti, Matteo},
  title = {Lower (1,3)-beta-d-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains},
  journal = {Clinical Microbiology and Infection},
  year = {2024},
  doi = {10.1016/j.cmi.2024.02.012}
}
Kostenlos starten →